Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Dow
Covington
US Army
UBS
Express Scripts
AstraZeneca
US Department of Justice
Merck
Deloitte

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 3,888,995

« Back to Dashboard

Summary for Patent: 3,888,995
Title: Fatty alcohol-propylene glycol vehicle
Abstract:A substantially non-aqueous medicant vehicle containing from 15 to 45 parts saturated fatty alcohol having from 16 to 24 carbons, from 45 to 85 parts glycol solvent, from 0 to 15 parts plasticizer, from 0 to 15 parts coupling agent, 0 to 20 parts penetrant, and if desired, other pharmaceutical adjuvants. This base is a suitable vehicle for all types of therapeutic agents for topical application including antibiotics, steroids, antihistamines, antiseptics, anesthetics, antibacterials, fungicides, and the like. The vehicle has shown particular advantages with anti-inflammatory topical corticoids.
Inventor(s): Katz; Martin (Atherton, CA), Neiman; Herbert M. (Philadelphia, PA)
Assignee: Syntex Corporation (PM)
Application Number:05/120,691
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 3,888,995

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 3,888,995

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Belgium 737875 ➤ Subscribe
Canada 989304 ➤ Subscribe
Switzerland 516312 ➤ Subscribe
Germany 1934334 ➤ Subscribe
Denmark 124857 ➤ Subscribe
France 2013281 ➤ Subscribe
United Kingdom 1259858 ➤ Subscribe
Hong Kong 26976 ➤ Subscribe
Netherlands 6911091 ➤ Subscribe
Netherlands 154665 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Accenture
Moodys
Federal Trade Commission
Citi
Fish and Richardson
Cantor Fitzgerald
US Department of Justice
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot